The mechanism of anti-SRP associated myopathy is mediated in a complement-dependent antibody as suggested by SRP co-localization on the cell surface with C3c, the activated product of the central component of the complement system C3 (Rojana-Udomsart et al., 2013). The gene discussed is UCN2; the disease is myopathy.